| abstract |
The present invention provides cationic peptidoglycans of formula I, which have a bacterial peptidoglycan mimetic structure and exhibit outstanding broad-spectrum activity against clinically important bacteria and fungi. The structural affinity of these compounds with microbial cell wall components facilitates their passage through the cytoplasmic membrane, leading to excellent antimicrobial activity and displaying high selectivity. . |